Suranganie Dharmawardhane

9PUBLICATIONS
35CO-AUTHORS
Molecular targetsCancer cell biologyFood properties (incl. characteristics and health benefits)Biologically active moleculesCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Mar 05, 2026
M6 metabolite contributes to the efficacy of the Rac/Cdc42 inhibitor MBQ-167 in metastatic breast cancer.

Nilmary Grafals-Ruiz, Julia I Medina, Jessica Colon Gonzalez

|Apr 04, 2025
VAV2 Drives EGFR-Mediated Rac1 Responses in Prostate Cancer.

Martin J Baker, Suli Zhang, Daniel Zhang

|Aug 01, 2024
Novel Inhibition of Central Carbon Metabolism Pathways by Rac and CDC42 inhibitor MBQ167 and Paclitaxel.

Ailed M Cruz-Collazo, Olga Katsara, Nilmary Grafals-Ruiz

|Aug 27, 2021
Soy and Frequent Dairy Consumption with Subsequent Equol Production Reveals Decreased Gut Health in a Cohort of Healthy Puerto Rican Women.

Mercedes Y Lacourt-Ventura, Brayan Vilanova-Cuevas, Delmarie Rivera-Rodríguez

|Jun 02, 2021
Rac inhibition as a novel therapeutic strategy for EGFR/HER2 targeted therapy resistant breast cancer.

Luis D Borrero-García, Maria Del Mar Maldonado, Julia Medina-Velázquez

|Apr 03, 2021
Rho Family GTPases in Cancer.

Suranganie Dharmawardhane

Pageof 2